Williams Hywel D, Sassene Philip, Kleberg Karen, Calderone Marilyn, Igonin Annabel, Jule Eduardo, Vertommen Jan, Blundell Ross, Benameur Hassan, Müllertz Anette, Porter Christopher J H, Pouton Colin W
Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia; Capsugel R&D, Strasbourg, France.
J Pharm Sci. 2014 Aug;103(8):2441-55. doi: 10.1002/jps.24067. Epub 2014 Jul 1.
The Lipid Formulation Classification System Consortium looks to develop standardized in vitro tests and to generate much-needed performance criteria for lipid-based formulations (LBFs). This article highlights the value of performing a second, more stressful digestion test to identify LBFs near a performance threshold and to facilitate lead formulation selection in instances where several LBF prototypes perform adequately under standard digestion conditions (but where further discrimination is necessary). Stressed digestion tests can be designed based on an understanding of the factors that affect LBF performance, including the degree of supersaturation generated on dispersion/digestion. Stresses evaluated included decreasing LBF concentration (↓LBF), increasing bile salt, and decreasing pH. Their capacity to stress LBFs was dependent on LBF composition and drug type: ↓LBF was a stressor to medium-chain glyceride-rich LBFs, but not more hydrophilic surfactant-rich LBFs, whereas decreasing pH stressed tolfenamic acid LBFs, but not fenofibrate LBFs. Lastly, a new Performance Classification System, that is, LBF composition independent, is proposed to promote standardized LBF comparisons, encourage robust LBF development, and facilitate dialogue with the regulatory authorities. This classification system is based on the concept that performance evaluations across three in vitro tests, designed to subject a LBF to progressively more challenging conditions, will enable effective LBF discrimination and performance grading.
脂质制剂分类系统联盟旨在开发标准化的体外测试,并为脂质基制剂(LBF)制定急需的性能标准。本文强调了进行第二次、压力更大的消化测试的价值,以识别接近性能阈值的LBF,并在多个LBF原型在标准消化条件下表现良好(但需要进一步区分)的情况下促进先导制剂的选择。可以基于对影响LBF性能的因素的理解来设计压力消化测试,包括分散/消化时产生的过饱和程度。评估的压力包括降低LBF浓度(↓LBF)、增加胆盐和降低pH值。它们对LBF施加压力的能力取决于LBF的组成和药物类型:↓LBF对富含中链甘油酯的LBF是一种压力源,但对富含亲水性表面活性剂的LBF则不是,而降低pH值会对托芬那酸LBF产生压力,但对非诺贝特LBF则不会。最后,提出了一种新的性能分类系统,即与LBF组成无关,以促进标准化的LBF比较,鼓励强大的LBF开发,并促进与监管机构的对话。该分类系统基于这样一种概念,即通过三项体外测试进行性能评估,旨在使LBF面临逐渐更具挑战性的条件,将能够有效地对LBF进行区分和性能分级。